The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: A systematic review

Psychiatry Research - Neuroimaging

Volumn 214, Issue 3, 2013, Pages 181-189

  James, Anthony ^a   James, Christine ^b   Thwaites, Thomas ^c  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Delta 9 tetrahydro cannabinol; Endocannabinoid; Grey matter; White matter

Indexed keywords

CANNABIS; ENDOCANNABINOID;

ADOLESCENCE; AMNESIA; BRAIN DEVELOPMENT; BRAIN REGION; BRAIN SIZE; CANNABIS ADDICTION; COGNITION; DIFFUSION TENSOR IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HIPPOCAMPUS; HUMAN; MEMORY; NEUROTRANSMISSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEX DIFFERENCE; SPATIAL MEMORY; WHITE MATTER; WORKING MEMORY;

DELTA-9-TETRAHYDRO-CANNABINOL; ENDOCANNABINOID; GREY MATTER; WHITE MATTER;

ADOLESCENT; BRAIN; CANNABIS; COGNITION; DRONABINOL; HEALTH; HUMANS; MARIJUANA ABUSE; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED; NEUROPSYCHOLOGICAL TESTS; PARIETAL LOBE; PSYCHOMETRICS; SCHIZOPHRENIA; SEX CHARACTERISTICS;

EID: 84888292304     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2013.07.012     Document Type: Review

References (83)

1. Abdullaev Y., Posner M.I., Nunnally R., Dishion T.J. Functional MRI evidence for inefficient attentional control in adolescent chronic cannabis abuse. Behavioural Brain Research 2010, 215:45-57.
2. Addington J., Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatrica Scandinavica 2007, 115:304-309.
3. Andreasson S., Allebeck P., Engstrom A., Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987, 2:1483-1486.
4. Arango C., Rapado-Castro M., Reig S., Castro-Fornieles J., Gonzalez-Pinto A., Otero S., Baeza I., Moreno C., Graell M., Janssen J., Parellada M., Moreno D., Bargallo N., Desco M. Progressive brain changes in children and adolescents with first-episode psychosis. Archives of General Psychiatry 2012, 69:16-26.
5. Arevalo-Martin A., Garcia-Ovejero D., Rubio-Araiz A., Gomez O., Molina-Holgado F., Molina-Holgado E. Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2. European Journal of Neuroscience 2007, 26:1548-1559.
6. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T.E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002, 325:1212-1213.
7. Ashtari M., Avants B., Cyckowski L., Cervellione K.L., Roofeh D., Cook P., Gee J., Sevy S., Kumra S. Medial temporal structures and memory functions in adolescents with heavy cannabis use. Journal of Psychiatric Research 2011, 45:1055-1066.
8. Ashtari M., Cervellione K., Cottone J., Ardekani B.A., Sevy S., Kumra S. Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. Journal of Psychiatric Research 2009, 43:189-204.
9. Bava S., Frank L.R., McQueeny T., Schweinsburg B.C., Schweinsburg A.D., Tapert S.F. Altered white matter microstructure in adolescent substance users. Psychiatry Research 2009, 173:228-237.
10. Benes F.M. Amygdalocortical circuitry in schizophrenia: from circuits to molecules. Neuropsychopharmacology 2010, 35:239-257.
11. Bhattacharyya S., Crippa J.A., Allen P., Martin-Santos R., Borgwardt S., Fusar-Poli P., Rubia K., Kambeitz J., O'Carroll C., Seal M.L., Giampietro V., Brammer M., Zuardi A.W., Atakan Z., McGuire P.K. Induction of psychosis by {delta}9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Archives of General Psychiatry 2012, 69:27-36.
12. Bhattacharyya S., Crippa J.A., Allen P., Martin-Santos R., Borgwardt S., Fusar-Poli P., Rubia K., Kambeitz J., O'Carroll C., Seal M.L., Giampietro V., Brammer M., Zuardi A.W., Atakan Z., McGuire P.K. Induction of psychosis by Delta9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Archives of General Psychiatry 2012, 69:27-36.
13. Bossong M.G., Niesink R.J. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Progress in Neurobiology 2010, 92:370-385.
14. Bourgeois J.P., Goldman-Rakic P.S., Rakic P. Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cerebral Cortex 1994, 4:78-96.
15. Cheetham A., Allen N.B., Whittle S., Simmons J., Yucel M., Lubman D.I. Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a 4-year longitudinal and prospective study. Biological Psychiatry 2011.
16. Cohen M., Rasser P.E., Peck G., Carr V.J., Ward P.B., Thompson P.M., Johnston P., Baker A., Schall U. Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. International Journal of Neuropsychopharmacology 2011, 1-11.
17. Constantinidis C., Williams G.V., Goldman-Rakic P.S. A role for inhibition in shaping the temporal flow of information in prefrontal cortex. Nature Neuroscience 2002, 5:175-180.
18. De Bellis M.D., Van Voorhees E., Hooper S.R., Gibler N., Nelson L., Hege S.G., Payne M.E., MacFall J. Diffusion tensor measures of the corpus callosum in adolescents with adolescent onset alcohol use disorders. Alcoholism, Clinical and Experimental Research 2008, 32:395-404.
19. Dekker N., Schmitz N., Peters B.D., van Amelsvoort T.A., Linszen D.H., de Haan L. Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Psychiatry Research 2011, 181:51-56.
20. Delisi L.E., Bertisch H.C., Szulc K.U., Majcher M., Brown K., Bappal A., Ardekani B.A. A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduction Journal 2006, 3:17.
21. Dragt S., Nieman D.H., Schultze-Lutter F., van der Meer F., Becker H., de Haan L., Dingemans P.M., Birchwood M., Patterson P., Salokangas R.K., Heinimaa M., Heinz A., Juckel G., Graf von Reventlow H., French P., Stevens H., Ruhrmann S., Klosterkotter J., Linszen D.H. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatrica Scandinavica 2012, 125:45-53.
22. Fergusson D.M., Horwood L.J., Swain-Campbell N.R. Cannabis dependence and psychotic symptoms in young people. Psychological Medicine 2003, 33:15-21.
23. Gabriels R.L., Agnew J.A., Beresford C., Morrow M.A., Mesibov G., Wamboldt M. Improving psychiatric hospital care for pediatric patients with autism spectrum disorders and intellectual disabilities. Autism Research and Treatment 2012, 2012:685053.
24. Giedd J.N. Structural magnetic resonance imaging of the adolescent brain. Annals of the New York Academy of Sciences 2004, 1021:77-85.
25. Gogtay N., Giedd J.N., Lusk L., Hayashi K.M., Greenstein D., Vaituzis A.C., Nugent T.F., Herman D.H., Clasen L.S., Toga A.W., Rapoport J.L., Thompson P.M. Dynamic mapping of human cortical development during childhood through early adulthood. Proceedings of the National Academy of Sciences USA 2004, 101:8174-8179.
26. Hardwick S., King L. Cannabis Potency Study 2008, Crown, London, (Office, H. (Ed.).
27. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H.U., van Os J. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 2005, 330:11.
28. Henquet C., Murray R., Linszen D., van Os J. The environment and schizophrenia: the role of cannabis use. Schizophrenia Bulletin 2005, 31:608-612.
29. Huttenlocher P.R. Synaptic density in human frontal cortex-developmental changes and effects of aging. Brain Research 1979, 163:195-205.
30. Jacobsen L.K., Pugh K.R., Constable R.T., Westerveld M., Mencl W.E. Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users. Biological Psychiatry 2007, 61:31-40.
31. Jacobus J., Goldenberg D., Wierenga C.E., Tolentino N.J., Liu T.T., Tapert S.F. Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users. Psychopharmacology 2012, (Berl).
32. Jacobus J., McQueeny T., Bava S., Schweinsburg B.C., Frank L.R., Yang T.T., Tapert S.F. White matter integrity in adolescents with histories of marijuana use and binge drinking. Neurotoxicology and Teratology 2009, 31:349-355.
33. James A., Hough M., James S., Winmill L., Burge L., Nijhawan S., Matthews P.M., Zarei M. Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS). Schizophrenia Research 2011.
34. Konings M., Henquet C., Maharajh H.D., Hutchinson G., Van Os J. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. Acta Psychiatrica Scandinavica 2008, 118:209-213.
35. Kumra S., Robinson P., Tambyraja R., Jensen D., Schimunek C., Houri A., Reis T., Lim K. Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2012, 51:171-180.
36. Kumra S., Thaden E., DeThomas C., Kranzler H. Correlates of substance abuse in adolescents with treatment-refractory schizophrenia and schizoaffective disorder. Schizophrenia Research 2005, 73:369-371.
37. Kyriakopoulos M., Frangou S. Recent diffusion tensor imaging findings in early stages of schizophrenia. Current Opinion in Psychiatry 2009, 22:168-176.
38. Lebel C., Gee M., Camicioli R., Wieler M., Martin W., Beaulieu C. Diffusion tensor imaging of white matter tract evolution over the lifespan. Neuroimage 2011.
39. Leeson V.C., Barnes T.R., Hutton S.B., Ron M.A., Joyce E.M. IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis. Schizophrenia Research 2009, 107:55-60.
40. Leeson V.C., Harrison I., Ron M.A., Barnes T.R., Joyce E.M. The Effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode Schizophrenia. Schizophrenia Bulletin 2011.
41. Lenroot R.K., Gogtay N., Greenstein D.K., Wells E.M., Wallace G.L., Clasen L.S., Blumenthal J.D., Lerch J., Zijdenbos A.P., Evans A.C., Thompson P.M., Giedd J.N. Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage 2007, 36:1065-1073.
42. Lopez-Larson M.P., Bogorodzki P., Rogowska J., McGlade E., King J.B., Terry J., Yurgelun-Todd D. Altered prefrontal and insular cortical thickness in adolescent marijuana users. Behavioural Brain Research 2011, 220:164-172.
43. Lorenzetti V., Lubman D.I., Whittle S., Solowij N., Yucel M. Structural MRI findings in long-term cannabis users: what do we know?. Substance Use and Misuse 2010, 45:1787-1808.
44. MacArthur G.J., Smith M.C., Melotti R., Heron J., Macleod J., Hickman M., Kipping R.R., Campbell R., Lewis G. Patterns of alcohol use and multiple risk behaviour by gender during early and late adolescence: the ALSPAC cohort. Journal of Public Health 2012, 34(1):i20-30.
45. Mackie K. Distribution of cannabinoid receptors in the central and peripheral nervous system. Handbook of Experimental Pharmacology 2005, 299-325.
46. Macleod J. Cannabis use and symptom experience amongst people with mental illness: a commentary on Degenhardt et al. Psychological Medicine 2007, 37:913-916.
47. Marco E.M., Garcia-Gutierrez M.S., Bermudez-Silva F.J., Moreira F.A., Guimaraes F., Manzanares J., Viveros M.P. Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. Frontiers in Behavioral Neuroscience 2011, 5:63.
48. Martin-Santos, R., Fagundo, A.B., Crippa, J.A., Atakan, Z., Bhattacharyya, S., Allen, P., Fusar-Poli, P., Borgwardt, S., Seal, M., Busatto, G.F., McGuire, P., Neuroimaging in cannabis use: a systematic review of the literature. Psychological Medicine. Vol. 40. Pp. 383-398.
49. Martin-Santos R., Fagundo A.B., Crippa J.A., Atakan Z., Bhattacharyya S., Allen P., Fusar-Poli P., Borgwardt S., Seal M., Busatto G.F., McGuire P. Neuroimaging in cannabis use: a systematic review of the literature. Psychological Medicine 2010, 40:383-398.
50. Mata I., Perez-Iglesias R., Roiz-Santianez R., Tordesillas-Gutierrez D., Pazos A., Gutierrez A., Vazquez-Barquero J.L., Crespo-Facorro B. Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use. Brain Research 2010, 1317:297-304.
51. Mauri M.C., Volonteri L.S., De Gaspari I.F., Colasanti A., Brambilla M.A., Cerruti L. Substance abuse in first-episode schizophrenic patients: a retrospective study. Clinical Practice and Epidemiology in Mental Health 2006, 2:4.
52. McQueeny T., Padula C.B., Price J., Medina K.L., Logan P., Tapert S.F. Gender effects on amygdala morphometry in adolescent marijuana users. Behavioural Brain Research 2011, 224:128-134.
53. Mechoulam R., Gaoni Y. The absolute configuration of delta-1-tetrahydrocannabinol, the major active constituent of hashish. Tetrahedron Letters 1967, 12:1109-1111.
54. Medina K.L., McQueeny T., Nagel B.J., Hanson K.L., Yang T.T., Tapert S.F. Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addiction Biology 2009, 14:457-468.
55. Medina K.L., Nagel B.J., Tapert S.F. Abnormal cerebellar morphometry in abstinent adolescent marijuana users. Psychiatry Research 2010, 182:152-159.
56. Meier M.H., Caspi A., Ambler A., Harrington H., Houts R., Keefe R.S., McDonald K., Ward A., Poulton R., Moffitt T.E. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences 2012.
57. Meijer J.H., Dekker N., Koeter M.W., Quee P.J., van Beveren N.J., Meijer C.J. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. Psychological Medicine 2011, 1-12.
58. Moher D., Altman D.G., Liberati A., Tetzlaff J. PRISMA statement. Epidemiology 2011, 22:128. (author reply).
59. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
60. Murray R.M., Lappin J., Di Forti M. Schizophrenia: from developmental deviance to dopamine dysregulation. European Neuropsychopharmacology 2008, 18(3):S129-134.
61. Padula C.B., Schweinsburg A.D., Tapert S.F. Spatial working memory performance and fMRI activation interaction in abstinent adolescent marijuana users. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors 2007, 21:478-487.
62. Paus T. Growth of white matter in the adolescent brain: myelin or axon?. Brain and Cognition 2010, 72:26-35.
63. Perrin J.S., Leonard G., Perron M., Pike G.B., Pitiot A., Richer L., Veillette S., Pausova Z., Paus T. Sex differences in the growth of white matter during adolescence. Neuroimage 2009, 45:1055-1066.
64. Peters B.D., Blaas J., de Haan L. Diffusion tensor imaging in the early phase of schizophrenia: what have we learned?. Journal of Psychiatric Research 2010, 44:993-1004.
65. Peters B.D., de Haan L., Vlieger E.J., Majoie C.B., den Heeten G.J., Linszen D.H. Recent-onset schizophrenia and adolescent cannabis use: MRI evidence for structural hyperconnectivity?. Psychopharmacology Bulletin 2009, 42:75-88.
66. Rabin R.A., Zakzanis K.K., George T.P. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophrenia Research 2011, 128:111-116.
67. Rolls E.T. The functions of the orbitofrontal cortex. Brain and Cognition 2004, 55:11-29.
68. Rosenberg D.R., Lewis D.A. Changes in the dopaminergic innervation of monkey prefrontal cortex during late postnatal development: a tyrosine hydroxylase immunohistochemical study. Biological Psychiatry 1994, 36:272-277.
69. Schweinsburg A.D., Brown S.A., Tapert S.F. The influence of marijuana use on neurocognitive functioning in adolescents. Current Drug Abuse Reviews 2008, 1:99-111.
70. Schweinsburg A.D., Nagel B.J., Schweinsburg B.C., Park A., Theilmann R.J., Tapert S.F. Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Research 2008, 163:40-51.
71. Schweinsburg A.D., Schweinsburg B.C., Medina K.L., McQueeny T., Brown S.A., Tapert S.F. The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users. Journal of Psychoactive Drugs 2010, 42:401-412.
72. Semple D.M., McIntosh A.M., Lawrie S.M. Cannabis as a risk factor for psychosis: systematic review. Journal of Psychopharmacology 2005, 19:187-194.
73. Sevy S., Robinson D.G., Napolitano B., Patel R.C., Gunduz-Bruce H., Miller R., McCormack J., Lorell B.S., Kane J. Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia. Schizophrenia Research 2010, 120:101-107.
74. Squeglia L.M., Jacobus J., Tapert S.F. The influence of substance use on adolescent brain development. Clin EEG Neurosci 2009, 40:31-38.
75. Stefanis N.C., Delespaul P., Henquet C., Bakoula C., Stefanis C.N., Van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004, 99:1333-1341.
76. Tapert S.F., Schweinsburg A.D., Drummond S.P., Paulus M.P., Brown S.A., Yang T.T., Frank L.R. Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology 2007, 194:173-183.
77. van Hell H.H., Bossong M.G., Jager G., Kristo G., van Osch M.J., Zelaya F., Kahn R.S., Ramsey N.F. Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study. International Journal of Neuropsychopharmacology 2011, 14:1377-1388.
78. van Os J., Bak M., Hanssen M., Bijl R.V., de Graaf R., Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 2002, 156:319-327.
79. Veen N.D., Selten J.P., van der Tweel I., Feller W.G., Hoek H.W., Kahn R.S. Cannabis use and age at onset of schizophrenia. American Journal of Psychiatry 2004, 161:501-506.
80. Yucel M., Bora E., Lubman D.I., Solowij N., Brewer W.J., Cotton S.M., Conus P., Takagi M.J., Fornito A., Wood S.J., McGorry P.D., Pantelis C. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin 2012, 38:316-330.
81. Yucel M., Zalesky A., Takagi M.J., Bora E., Fornito A., Ditchfield M., Egan G.F., Pantelis C., Lubman D.I. White-matter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study. Journal of Psychiatry and Neuroscience 2010, 35:409-412.
82. Zalesky A., Solowij N., Yucel M., Lubman D.I., Takagi M., Harding I.H., Lorenzetti V., Wang R., Searle K., Pantelis C., Seal M. Effect of long-term cannabis use on axonal fibre connectivity. Brain 2012, 135:2245-2255.
83. Zammit S., Allebeck P., Andreasson S., Lundberg I., Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002, 325:1199.